These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34046917)

  • 1. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
    Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
    J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
    Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
    Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
    Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
    J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
    Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
    Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.
    Pan H; Yang M; Lu L; Tao B; He X; Chen H; Yi H; Tang S
    Pharmacogenet Genomics; 2019 Jun; 29(4):84-90. PubMed ID: 30720667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
    Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
    Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 9.  NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.
    Lv X; Tang S; Xia Y; Zhang Y; Wu S; Yang Z; Li X; Tu D; Chen Y; Deng P; Ma Y; Chen D; Chen R; Zhan S
    Ann Hepatol; 2012; 11(5):700-7. PubMed ID: 22947533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
    Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
    J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
    Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
    Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of
    Wang N; Chen X; Hao Z; Yi H; Tang S
    Xenobiotica; 2022 May; 52(5):527-533. PubMed ID: 35735268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
    Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
    J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on hereditary susceptibility genetic markers to anti-tuberculosis drug induced liver injury in Chinese population].
    Zhou CX; Li M; Huai C; He L; Qin SY
    Yi Chuan; 2020 Apr; 42(4):374-379. PubMed ID: 32312706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
    Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
    Zhang M; Zhu J; Wang N; Liu W; Lu L; Pan H; He X; Yi H; Tang S
    J Clin Pharm Ther; 2022 Aug; 47(8):1276-1283. PubMed ID: 35470464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of silent information regulator 1 (SIRT1) gene polymorphisms in antituberculosis- drug-induced hepatotoxicity in a prospective cohort study.
    Wang Y; Yan XY; Wu JC; Ji GY; Wu SQ; Huang WW; Chen G; Sandford AJ; He JQ
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):775-81. PubMed ID: 26952036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children.
    Li Y; Tang H; Qi H; Shen C; Sun L; Li J; Xu F; Jiao W; Yang X; Shen A
    Tuberculosis (Edinb); 2018 Jul; 111():71-77. PubMed ID: 30029918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen type XVIII alpha 1 chain (COL18A1) variants affect the risk of anti-tuberculosis drug-induced hepatotoxicity: A prospective study.
    Cheng Y; Jiao L; Li W; Wang J; Lin Z; Lai H; Ying B
    J Clin Lab Anal; 2021 Feb; 35(2):e23630. PubMed ID: 33296124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.